Medera to List on NASDAQ After Merger with Keen Vision Acquisition Corp.

Exec Edge

2024-09-05

By Karen Roman

Biotechnology company Medera Inc. said it entered a definitive merger agreement with Keen Vision Acquisition Corp. (Nasdaq: KVAC), with the combined company having an implied initial enterprise value of approximately $622.6 million.

The transaction will close in the fourth quarter and the combined company will be called Medera Inc., both firms said in a statement.

Medera is expected to have $40 million or more in available liquidity as part of the closing conditions for the business combination, they stated.

“Achieving a Nasdaq listing will allow Medera to be better positioned for advancing our various clinical and preclinical programs, enabling more efficient development aimed at bringing novel therapeutic solutions to patients with unmet needs,” stated Ronald Li, PhD, CEO and Founder of Medera.

Contact:

Exec Edge

Editor@executives-edge.com

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2465826524"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2465826524\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2465826524?lang=zh_TW&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/AO.04eMXeQXrFNkEWwWJ4Q--~B/aD02MTI7dz0yMTcwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/exec_edge_220/6bd1e52a0f2c6efe4ea387247898934d","is_english":true,"pubTime":"2024-09-05 23:57","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2465826524","market":"us","top_or_hot":-1,"title":"Medera to List on NASDAQ After Merger with Keen Vision Acquisition Corp.","media":"Exec Edge","content":"<html><body><p><img height=\"612\" src=\"https://s.yimg.com/uu/api/res/1.2/fs94hglSmggkAYEKO.PktA--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/exec_edge_220/6bd1e52a0f2c6efe4ea387247898934d\" width=\"2170\"/></p>\n<p>By Karen Roman</p>\n<p>Biotechnology company Medera Inc. said it entered a definitive merger agreement with <a href=\"https://laohu8.com/S/KVACU\">Keen Vision Acquisition Corp.</a> (Nasdaq: KVAC), with the combined company having an implied initial enterprise value of approximately $622.6 million.</p>\n<p>The transaction will close in the fourth quarter and the combined company will be called Medera Inc., both firms said in a statement.</p>\n<p>Medera is expected to have $40 million or more in available liquidity as part of the closing conditions for the business combination, they stated.</p>\n<p>“Achieving a Nasdaq listing will allow Medera to be better positioned for advancing our various clinical and preclinical programs, enabling more efficient development aimed at bringing novel therapeutic solutions to patients with unmet needs,” stated Ronald Li, PhD, CEO and Founder of Medera.</p>\n<p>Contact:</p>\n<div>\nExec Edge\n</div>\n<div>\n<p>Editor@executives-edge.com</p>\n</div>\n</body></html>","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Medera to List on NASDAQ After Merger with Keen Vision Acquisition Corp.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMedera to List on NASDAQ After Merger with Keen Vision Acquisition Corp.\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Exec Edge</strong><span class=\"h-time small\">2024-09-05 23:57</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body><p><img height=\"612\" src=\"https://s.yimg.com/uu/api/res/1.2/fs94hglSmggkAYEKO.PktA--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/exec_edge_220/6bd1e52a0f2c6efe4ea387247898934d\" width=\"2170\"/></p>\n<p>By Karen Roman</p>\n<p>Biotechnology company Medera Inc. said it entered a definitive merger agreement with <a href=\"https://laohu8.com/S/KVACU\">Keen Vision Acquisition Corp.</a> (Nasdaq: KVAC), with the combined company having an implied initial enterprise value of approximately $622.6 million.</p>\n<p>The transaction will close in the fourth quarter and the combined company will be called Medera Inc., both firms said in a statement.</p>\n<p>Medera is expected to have $40 million or more in available liquidity as part of the closing conditions for the business combination, they stated.</p>\n<p>“Achieving a Nasdaq listing will allow Medera to be better positioned for advancing our various clinical and preclinical programs, enabling more efficient development aimed at bringing novel therapeutic solutions to patients with unmet needs,” stated Ronald Li, PhD, CEO and Founder of Medera.</p>\n<p>Contact:</p>\n<div>\nExec Edge\n</div>\n<div>\n<p>Editor@executives-edge.com</p>\n</div>\n</body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://finance.yahoo.com/news/medera-list-nasdaq-merger-keen-155722833.html\">Exec Edge</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":".IXIC","symbol_name":"NASDAQ Composite","start_time":0,"source_url":"https://finance.yahoo.com/news/medera-list-nasdaq-merger-keen-155722833.html","article_id":"2465826524","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/AO.04eMXeQXrFNkEWwWJ4Q--~B/aD02MTI7dz0yMTcwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/exec_edge_220/6bd1e52a0f2c6efe4ea387247898934d"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2465826524","pubTimestamp":1725551842,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Biotechnology company Medera Inc. said it entered a definitive merger agreement with Keen Vision Acquisition Corp. , with the combined company having an implied initial enterprise value of approximately $622.6 million.The transaction will close in the fourth quarter and the combined company will be called Medera Inc., both firms said in a statement.Medera is expected to have $40 million or more in available liquidity as part of the closing conditions for the business combination, they stated.“Achieving a Nasdaq listing will allow Medera to be better positioned for advancing our various clinical and preclinical programs, enabling more efficient development aimed at bringing novel therapeutic solutions to patients with unmet needs,” stated Ronald Li, PhD, CEO and Founder of Medera.","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{".IXIC":"NASDAQ Composite","BK4588":"碎股","KVACU":"Keen Vision Acquisition Corp.","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","BK4585":"ETF&股票定投概念","BK4112":"金融交易所和数据","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","NDAQ":"纳斯达克OMX交易所","KVACW":"KEEN VISION ACQUISITION CORPORATION C/WTS 15/03/2028 (TO PUR ORD)","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","KVAC":"KEEN VISION ACQUISITION CORPORATION"},"translate_title":"Medera与Keen Vision Acquisition Corp合并后将在纳斯达克上市。","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{".IXIC":1,"KVAC":0.9,"KVACU":1,"KVACW":0.9,"NDAQ":1},"content_text":"By Karen Roman\nBiotechnology company Medera Inc. said it entered a definitive merger agreement with Keen Vision Acquisition Corp. (Nasdaq: KVAC), with the combined company having an implied initial enterprise value of approximately $622.6 million.\nThe transaction will close in the fourth quarter and the combined company will be called Medera Inc., both firms said in a statement.\nMedera is expected to have $40 million or more in available liquidity as part of the closing conditions for the business combination, they stated.\n“Achieving a Nasdaq listing will allow Medera to be better positioned for advancing our various clinical and preclinical programs, enabling more efficient development aimed at bringing novel therapeutic solutions to patients with unmet needs,” stated Ronald Li, PhD, CEO and Founder of Medera.\nContact:\n\nExec Edge\n\n\nEditor@executives-edge.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}